98%
921
2 minutes
20
Introduction: Persons with multiple sclerosis (MS) frequently experience symptoms of anxiety. There is a large unmet need for effective and accessible interventions.
Objectives: To assess the effect of exercise on symptoms of anxiety in persons with MS, consider characteristics associated with effectiveness, and evaluate intervention design reporting.
Methods: This systematic review and meta-analysis included randomised controlled exercise trials in persons with MS. MEDLINE, Embase, PsycINFO, CENTRAL, CINAHL, Scopus, Web of Science and PEDro were searched up to November 2024. The primary outcome was the post-intervention difference in anxiety symptoms between intervention and inactive control groups. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool. We pooled standardised mean differences using a restricted maximum likelihood random-effects model.
Results: This systematic review of 18 randomised controlled trials identified a small positive effect of exercise on anxiety symptoms in persons with MS (SMD: 0.26, 95% CI: 0.04, 0.48) with moderate heterogeneity between trials (I: 37.94%, τ: 0.0962). All trials had a high risk of bias, as they relied on self-reported anxiety measures in unblinded participants. Few trials were pre-registered, and none focused on anxiety as the primary outcome. Authors infrequently reported intervention designs incorporating stakeholder engagement, expert engagement, and evidence-based and/or behavioural frameworks.
Conclusions: Exercise can reduce symptoms of anxiety in persons with MS. This is a promising result, given that exercise is beneficial for general health and is a safe and accessible treatment option.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.msard.2025.106709 | DOI Listing |
Cuad Bioet
September 2025
Facultad de Farmacia y Nutrición de la Universidad de Navarra, Irunlarrea, 1, 31008 Pamplona.
In recent years, there has been a significant increase in minors with gender dysphoria (GD) seeking transition treatments, including puberty blockers and cross-sex hormones. The developing child's brain exhibits structural and functional differences in children with GD compared to cisgender children, particularly in areas where sex differences exist. Brain development during childhood and adolescence is strongly influenced by sex hormones.
View Article and Find Full Text PDFMenopause
September 2025
Bayer Consumer Care, Basel, Switzerland.
Importance: Sleep disturbances are common during and after the menopause transition, with potential effects on morbidity and quality of life; however, they may be underdiagnosed and undertreated.
Objective: We carried out a systematic literature review to investigate the prevalence and impact of sleep disturbances associated with menopause on women's health-related quality of life across the stages of menopause.
Evidence Review: Searches were conducted in PubMed and Excerpta Medica Database to identify articles published between 2013 and 2023 containing evidence for the impact of sleep quality on health-related quality of life and the epidemiology of sleep disturbances in women in menopause.
PLOS Glob Public Health
September 2025
Department of Family Medicine, Aga Khan University, Karachi, Pakistan.
The objective of the study was to evaluate the prevalence of cardiometabolic multimorbidity and symptoms of common mental disorders, including depression, anxiety, and stress, and association between the two, in primary care clinics for low-income, urban population in Karachi, Pakistan. We performed a descriptive cross-sectional study at two primary healthcare clinics, catering predominantly to low-income families in Karachi. Adults, aged 30 years and above, coming to the two clinics for acute illnesses or for regular follow-up of chronic conditions were recruited.
View Article and Find Full Text PDFNeuropsychobiology
September 2025
Introduction: Anxiety has been described in the initial stages of schizophrenia, and affective flattening in the chronic illness. The etiology remains unknown. Ketamine, a noncompetitive N-Methyl-D-amino-aspartate acid (NMDA) receptor antagonist, is used in rats as a translational model of schizophrenia.
View Article and Find Full Text PDFActa Neurol Belg
September 2025
Neuroscience Research Australia, University of New South Wales, Sydney, Australia.
Objectives: Patients diagnosed with amyotrophic lateral sclerosis (ALS) typically describe symptoms of fatigue. Despite this frequency, the underlying mechanisms of fatigue are poorly understood, and are likely multifactorial. To help clarify mechanisms, the present systematic review was undertaken to determine the risk factors related to fatigue in ALS.
View Article and Find Full Text PDF